| Clemente V. Zulueta, Jr., Md, Pllc | |
|
95 Jackson Hts Ste 201 Jackson KY 41339-6500 | |
| (606) 693-1078 | |
| (606) 693-1079 |
| Full Name | Clemente V. Zulueta, Jr., Md, Pllc |
|---|---|
| Speciality | Internal Medicine |
| Location | 95 Jackson Hts, Jackson, Kentucky |
| Authorized Official Name and Position | Clemente V. Zulueta (OWNER) |
| Authorized Official Contact | 6066931078 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Clemente V. Zulueta, Jr., Md, Pllc Po Box 908 Jackson KY 41339-0908 Ph: (606) 693-1078 | Clemente V. Zulueta, Jr., Md, Pllc 95 Jackson Hts Ste 201 Jackson KY 41339-6500 Ph: (606) 693-1078 |
| NPI Number | 1275543175 |
|---|---|
| Provider Enumeration Date | 08/09/2006 |
| Last Update Date | 07/02/2012 |
| Medicare PECOS PAC ID | 2264419811 |
|---|---|
| Medicare Enrollment ID | O20040701001257 |
News Archive
Syntaxin, a biotechnology company developing novel biopharmaceuticals to control cell secretion, today announces its partner Allergan, Inc has initiated two Phase II trials to evaluate the safety and efficacy of its re-targeted endopeptidase drug candidate AGN-214868. The Phase II trials will be focused on patients with post herpetic neuralgia (PHN) and overactive bladder.
Pregnant women with anemia are twice as likely to need blood transfusions after a cesarean delivery, as those without the condition, according to a study being presented at the ANESTHESIOLOGY 2019 annual meeting.
After more than a year of political wrangling, Congress finished its work on health care reform Thursday night when the House passed a Senate-changed bill of fixes to the new law.
National Institutes of Health and Colorado State University scientists have provided experimental evidence supporting dromedary camels as the primary reservoir, or carrier, of Middle East respiratory syndrome coronavirus (MERS-CoV).
Prostate cancer cells that defy treatment and display heightened tumor-generating capacity can be identified by levels of prostate specific antigen (PSA) expressed in the tumor cells, a research team led by scientists at The University of Texas MD Anderson Cancer Center reports in the May 3 edition of Cell Stem Cell.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275543175 | NPI | - | NPPES |
| 31-000847 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | (* (Not Available)) | Primary |
| Provider Name | Clemente V Zulueta |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1831109743 PECOS PAC ID: 7719872308 Enrollment ID: I20040223000054 |
News Archive
Syntaxin, a biotechnology company developing novel biopharmaceuticals to control cell secretion, today announces its partner Allergan, Inc has initiated two Phase II trials to evaluate the safety and efficacy of its re-targeted endopeptidase drug candidate AGN-214868. The Phase II trials will be focused on patients with post herpetic neuralgia (PHN) and overactive bladder.
Pregnant women with anemia are twice as likely to need blood transfusions after a cesarean delivery, as those without the condition, according to a study being presented at the ANESTHESIOLOGY 2019 annual meeting.
After more than a year of political wrangling, Congress finished its work on health care reform Thursday night when the House passed a Senate-changed bill of fixes to the new law.
National Institutes of Health and Colorado State University scientists have provided experimental evidence supporting dromedary camels as the primary reservoir, or carrier, of Middle East respiratory syndrome coronavirus (MERS-CoV).
Prostate cancer cells that defy treatment and display heightened tumor-generating capacity can be identified by levels of prostate specific antigen (PSA) expressed in the tumor cells, a research team led by scientists at The University of Texas MD Anderson Cancer Center reports in the May 3 edition of Cell Stem Cell.
› Verified 6 days ago
| Provider Name | Elizabeth Potter |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1154478162 PECOS PAC ID: 7113997339 Enrollment ID: I20040727000542 |
News Archive
Syntaxin, a biotechnology company developing novel biopharmaceuticals to control cell secretion, today announces its partner Allergan, Inc has initiated two Phase II trials to evaluate the safety and efficacy of its re-targeted endopeptidase drug candidate AGN-214868. The Phase II trials will be focused on patients with post herpetic neuralgia (PHN) and overactive bladder.
Pregnant women with anemia are twice as likely to need blood transfusions after a cesarean delivery, as those without the condition, according to a study being presented at the ANESTHESIOLOGY 2019 annual meeting.
After more than a year of political wrangling, Congress finished its work on health care reform Thursday night when the House passed a Senate-changed bill of fixes to the new law.
National Institutes of Health and Colorado State University scientists have provided experimental evidence supporting dromedary camels as the primary reservoir, or carrier, of Middle East respiratory syndrome coronavirus (MERS-CoV).
Prostate cancer cells that defy treatment and display heightened tumor-generating capacity can be identified by levels of prostate specific antigen (PSA) expressed in the tumor cells, a research team led by scientists at The University of Texas MD Anderson Cancer Center reports in the May 3 edition of Cell Stem Cell.
› Verified 6 days ago
News Archive
Syntaxin, a biotechnology company developing novel biopharmaceuticals to control cell secretion, today announces its partner Allergan, Inc has initiated two Phase II trials to evaluate the safety and efficacy of its re-targeted endopeptidase drug candidate AGN-214868. The Phase II trials will be focused on patients with post herpetic neuralgia (PHN) and overactive bladder.
Pregnant women with anemia are twice as likely to need blood transfusions after a cesarean delivery, as those without the condition, according to a study being presented at the ANESTHESIOLOGY 2019 annual meeting.
After more than a year of political wrangling, Congress finished its work on health care reform Thursday night when the House passed a Senate-changed bill of fixes to the new law.
National Institutes of Health and Colorado State University scientists have provided experimental evidence supporting dromedary camels as the primary reservoir, or carrier, of Middle East respiratory syndrome coronavirus (MERS-CoV).
Prostate cancer cells that defy treatment and display heightened tumor-generating capacity can be identified by levels of prostate specific antigen (PSA) expressed in the tumor cells, a research team led by scientists at The University of Texas MD Anderson Cancer Center reports in the May 3 edition of Cell Stem Cell.
› Verified 6 days ago
St. John Neumann's Extended Hours Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1389 Highway 15 North, Jackson, KY 41339 Phone: 606-666-4011 Fax: 606-666-5801 | |
Juniper Health Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 90 Lbj Rd, Jackson, KY 41339 Phone: 606-464-0151 Fax: 606-464-0152 | |
Juniper Health Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2307 Bobcat Ln, Jackson, KY 41339 Phone: 606-464-0151 Fax: 606-464-0152 | |
United Clinics Of Kentucky Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 95 Jackson Hts Ste A, Jackson, KY 41339 Phone: 606-718-6505 Fax: 606-272-6180 | |
Saint Mark's Family And Specialty Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 95 Jackson Hts, Jackson, KY 41339 Phone: 606-693-0199 Fax: 606-693-0299 | |
Juniper Health Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 244 L B J Rd, Jackson, KY 41339 Phone: 606-464-0151 Fax: 606-464-0152 |